Status:
COMPLETED
Subantimicrobial Doxycycline in Acne
Lead Sponsor:
Michigan State University
Conditions:
Acne Vulgaris
Pediatrics
Eligibility:
All Genders
13-17 years
Phase:
PHASE4
Brief Summary
Antibiotic resistance is a public health problem that worsens the more physicians prescribe standard dose antibiotics for acne. Regardless of race, acne vulgaris is one of the most common dermatologic...
Eligibility Criteria
Inclusion
- Documented moderate to severe facial acne
Exclusion
- Other skin conditions on the face
- Previous antibiotic treatment for acne
- Use of antibiotics for any reason within the past month
- Use of new prescription regiment for acne within the last 3 months
- Positive pregnancy test in the clinic
- Cognitive impairments
Key Trial Info
Start Date :
November 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 8 2021
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05399290
Start Date
November 19 2020
End Date
November 8 2021
Last Update
April 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Messenger Dermatology Clinic
Lansing, Michigan, United States, 48912